
    
      Study period between 1/2/2000 and 31/12/2003 Follow-up until 31/12/2007

      Patient will be stratified according to adherence to HS during the first 2 postoperative
      years Good adherent patient: patient performed ≥ 80% of predicted HS within 24 months
      Moderate adherent patient: patient performed ≥ 50% of predicted HS within 24 months
      Non-adherent patient: patient performed < 50% of predicted HS within 24 months.

      Primary outcome measure graft loss at end of follow-up

      Secondary outcome measure number of acute rejections during follow-up number of
      hospitalisation during follow-up Incidence of bronchiolitis obliterans syndrome during
      follow-up
    
  